Delivery Order SPE2DB20D2104-SPE2DB24FT79S
- Not listed
- This federal contract award, with ID SPE2DB20D2001|SPE2DB24FM42E, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,485.50 delivery order contract is for the supply of 4,563,458,779 units of Rosuvastatin Calcium 40 mg tablets, with a completion date of January 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $54,303.29, is for the delivery of Rosuvastatin Calcium 40 mg tablets, a cardiovascular medication, to support military and government healthcare programs. The contract has an ultimate completion date of January 31, 2024 and is a firm fixed-price delivery order. No set-aside designation was used, indicating open competition....
- This federal contract award, identified as SPE2DB20D2014|SPE2DB24FA26F, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,228.46 firm fixed-price delivery order is for the supply of 500 units of Rosuvastatin Calcium 40 mg tablets. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award, valued at $17,373.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Rosuvastatin Calcium 5 mg tablets in quantities of 500 tablets, with a completion date of April 18, 2023. This is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,154.47 Firm Fixed Price delivery order is for the supply of Rosuvastatin Calcium 10 mg tablets to DLA facilities. The award is not associated with a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,668.55 firm fixed-price delivery order contract covers the supply of 500 count bottles of 5 mg Rosuvastatin Calcium tablets. The contract has an ultimate completion date of July 30, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
- This contract award from the Defense Logistics Agency (DLA) is for the delivery of Rosuvastatin Calcium 5 mg tablets to support federal healthcare programs. The $26,251.48 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is for the delivery of 4,563,482,111 units of Rosuvastatin Calcium 20 mg tablets in 500-count bottles, with a firm fixed price of $6,400.32 and a completion date of January 31, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The $5,421.05 firm fixed price contract is for the delivery of 4,564,603,768 units of Rosuvastatin Calcium 10 mg tablets by May 15, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense (DoD)...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ROSUVASTATIN CALCIUM 40 MG TAB 500S. The contract has a potential value of $16,652.31 and a completion date of February 22, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and will deliver the pharmaceutical products from its Corporate Office location in Conshohocken,...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FT79SDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,564,376 units of Rosuvastatin Calcium 40 mg tablets, a cardiovascular medication, to the Defense Logistics Agency (DLA). The $12,862.14 firm fixed-price delivery order has an ultimate completion date of April 24, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.9k | 4/23/24 |